Nasus Pharma is trading 8.5% higher at $3.50 on October 23, 2026, with no company-specific announcement identified for the move.
- The prior session closed at $3.23, up 5.56%.
- The latest located company update was the September 29 announcement on NS003 Phase 1 trial enrollment and dosing.
- Healthcare-sector weakness and mixed broader markets do not clearly explain the upward move.